Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
enpharmacorp.com

See what CB Insights has to offer

Founded Year

2000

Stage

Growth Equity | Dead

About EnPharma

Developer of drugs based upon small molecule technology initially developed at the University of Ottawa. The company develops small molecules, which target peripheral pathways and gut receptors controlling to regulate food intake and obesity in humans and animals. It focuses on gastrointestinal pharmacology of ‘feed refusal syndrome’.

EnPharma Headquarter Location

451 Smyth Road, Suite 2230 Level 2, Health Sciences Building

Ottawa, Ontario, K1H 8M5,

Canada

(613)562-5800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.